Bone resorption levels by age and menopausal status in 5,157 women

Linda L. Lewis, Joan L Shaver, Nancy F. Woods, Martha J. Lentz, Kevin C. Cain, Vicky Hertig, Sandra Heidergott

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Objective: The purpose of this study was to describe bone resorption activity using a biochemical marker according to the categories of age, menopausal status, and selected drug/supplement use in middle-aged and elderly community-based women. Design: This was a cross-sectional study that assessed urinary cross-linked N-telopeptide of type I collagen (NTx) and used self-report data to group women as premenopausal (Pre), perimenopausal (Peri), postmenopausal without hormone replacement therapy (Post), and postmenopausal with hormone replacement therapy (HRT). Results: Mean NTx values were found to be significantly different by group and controlling for age (p = 0.001), with post hoc tests showing all pairwise group comparisons as significantly different (p = 0.001), except that the Pre and HRT groups were not significantly different. Both the Peri and the Post NTx levels were significantly higher than the Pre and the HRT groups'. NTx values in the Peri group varied with age-the youngest Peri women were similar to Pre women, and the oldest Peri women were similar to Post women. Significantly lower NTx levels were found only in the Post (p = 0.009) and HRT (p < 0.001) groups using diuretics compared with nonuse and only in the HRT group using calcium supplements compared with nonuse (p = 0.006). No differences by thyroid use were found. With a biochemical marker, the results showed that bone resorption activity differences could be demarcated in women according to age, estimated menopausal stage, and selected drug/supplement use. Conclusions: These results support the usefulness of NTx assessment for indicating bone resorption activity and therefore the potential for osteoporosis or for monitoring the efficacy of antiresorptive therapies.

Original languageEnglish (US)
Pages (from-to)42-52
Number of pages11
JournalMenopause
Volume7
Issue number1
StatePublished - 2000
Externally publishedYes

Fingerprint

Bone Resorption
Hormone Replacement Therapy
Estrogen Replacement Therapy
Biomarkers
Collagen Type I
Diuretics
Pharmaceutical Preparations
Self Report
Osteoporosis
Thyroid Gland
Age Groups
Cross-Sectional Studies
Calcium

Keywords

  • Bone resorption
  • Hormone replacement therapy
  • Menopause
  • Osteoporosis

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Lewis, L. L., Shaver, J. L., Woods, N. F., Lentz, M. J., Cain, K. C., Hertig, V., & Heidergott, S. (2000). Bone resorption levels by age and menopausal status in 5,157 women. Menopause, 7(1), 42-52.

Bone resorption levels by age and menopausal status in 5,157 women. / Lewis, Linda L.; Shaver, Joan L; Woods, Nancy F.; Lentz, Martha J.; Cain, Kevin C.; Hertig, Vicky; Heidergott, Sandra.

In: Menopause, Vol. 7, No. 1, 2000, p. 42-52.

Research output: Contribution to journalArticle

Lewis, LL, Shaver, JL, Woods, NF, Lentz, MJ, Cain, KC, Hertig, V & Heidergott, S 2000, 'Bone resorption levels by age and menopausal status in 5,157 women', Menopause, vol. 7, no. 1, pp. 42-52.
Lewis LL, Shaver JL, Woods NF, Lentz MJ, Cain KC, Hertig V et al. Bone resorption levels by age and menopausal status in 5,157 women. Menopause. 2000;7(1):42-52.
Lewis, Linda L. ; Shaver, Joan L ; Woods, Nancy F. ; Lentz, Martha J. ; Cain, Kevin C. ; Hertig, Vicky ; Heidergott, Sandra. / Bone resorption levels by age and menopausal status in 5,157 women. In: Menopause. 2000 ; Vol. 7, No. 1. pp. 42-52.
@article{cc00bfe5981a4e60a060fc36ca5bb73d,
title = "Bone resorption levels by age and menopausal status in 5,157 women",
abstract = "Objective: The purpose of this study was to describe bone resorption activity using a biochemical marker according to the categories of age, menopausal status, and selected drug/supplement use in middle-aged and elderly community-based women. Design: This was a cross-sectional study that assessed urinary cross-linked N-telopeptide of type I collagen (NTx) and used self-report data to group women as premenopausal (Pre), perimenopausal (Peri), postmenopausal without hormone replacement therapy (Post), and postmenopausal with hormone replacement therapy (HRT). Results: Mean NTx values were found to be significantly different by group and controlling for age (p = 0.001), with post hoc tests showing all pairwise group comparisons as significantly different (p = 0.001), except that the Pre and HRT groups were not significantly different. Both the Peri and the Post NTx levels were significantly higher than the Pre and the HRT groups'. NTx values in the Peri group varied with age-the youngest Peri women were similar to Pre women, and the oldest Peri women were similar to Post women. Significantly lower NTx levels were found only in the Post (p = 0.009) and HRT (p < 0.001) groups using diuretics compared with nonuse and only in the HRT group using calcium supplements compared with nonuse (p = 0.006). No differences by thyroid use were found. With a biochemical marker, the results showed that bone resorption activity differences could be demarcated in women according to age, estimated menopausal stage, and selected drug/supplement use. Conclusions: These results support the usefulness of NTx assessment for indicating bone resorption activity and therefore the potential for osteoporosis or for monitoring the efficacy of antiresorptive therapies.",
keywords = "Bone resorption, Hormone replacement therapy, Menopause, Osteoporosis",
author = "Lewis, {Linda L.} and Shaver, {Joan L} and Woods, {Nancy F.} and Lentz, {Martha J.} and Cain, {Kevin C.} and Vicky Hertig and Sandra Heidergott",
year = "2000",
language = "English (US)",
volume = "7",
pages = "42--52",
journal = "Menopause",
issn = "1072-3714",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Bone resorption levels by age and menopausal status in 5,157 women

AU - Lewis, Linda L.

AU - Shaver, Joan L

AU - Woods, Nancy F.

AU - Lentz, Martha J.

AU - Cain, Kevin C.

AU - Hertig, Vicky

AU - Heidergott, Sandra

PY - 2000

Y1 - 2000

N2 - Objective: The purpose of this study was to describe bone resorption activity using a biochemical marker according to the categories of age, menopausal status, and selected drug/supplement use in middle-aged and elderly community-based women. Design: This was a cross-sectional study that assessed urinary cross-linked N-telopeptide of type I collagen (NTx) and used self-report data to group women as premenopausal (Pre), perimenopausal (Peri), postmenopausal without hormone replacement therapy (Post), and postmenopausal with hormone replacement therapy (HRT). Results: Mean NTx values were found to be significantly different by group and controlling for age (p = 0.001), with post hoc tests showing all pairwise group comparisons as significantly different (p = 0.001), except that the Pre and HRT groups were not significantly different. Both the Peri and the Post NTx levels were significantly higher than the Pre and the HRT groups'. NTx values in the Peri group varied with age-the youngest Peri women were similar to Pre women, and the oldest Peri women were similar to Post women. Significantly lower NTx levels were found only in the Post (p = 0.009) and HRT (p < 0.001) groups using diuretics compared with nonuse and only in the HRT group using calcium supplements compared with nonuse (p = 0.006). No differences by thyroid use were found. With a biochemical marker, the results showed that bone resorption activity differences could be demarcated in women according to age, estimated menopausal stage, and selected drug/supplement use. Conclusions: These results support the usefulness of NTx assessment for indicating bone resorption activity and therefore the potential for osteoporosis or for monitoring the efficacy of antiresorptive therapies.

AB - Objective: The purpose of this study was to describe bone resorption activity using a biochemical marker according to the categories of age, menopausal status, and selected drug/supplement use in middle-aged and elderly community-based women. Design: This was a cross-sectional study that assessed urinary cross-linked N-telopeptide of type I collagen (NTx) and used self-report data to group women as premenopausal (Pre), perimenopausal (Peri), postmenopausal without hormone replacement therapy (Post), and postmenopausal with hormone replacement therapy (HRT). Results: Mean NTx values were found to be significantly different by group and controlling for age (p = 0.001), with post hoc tests showing all pairwise group comparisons as significantly different (p = 0.001), except that the Pre and HRT groups were not significantly different. Both the Peri and the Post NTx levels were significantly higher than the Pre and the HRT groups'. NTx values in the Peri group varied with age-the youngest Peri women were similar to Pre women, and the oldest Peri women were similar to Post women. Significantly lower NTx levels were found only in the Post (p = 0.009) and HRT (p < 0.001) groups using diuretics compared with nonuse and only in the HRT group using calcium supplements compared with nonuse (p = 0.006). No differences by thyroid use were found. With a biochemical marker, the results showed that bone resorption activity differences could be demarcated in women according to age, estimated menopausal stage, and selected drug/supplement use. Conclusions: These results support the usefulness of NTx assessment for indicating bone resorption activity and therefore the potential for osteoporosis or for monitoring the efficacy of antiresorptive therapies.

KW - Bone resorption

KW - Hormone replacement therapy

KW - Menopause

KW - Osteoporosis

UR - http://www.scopus.com/inward/record.url?scp=0033985340&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033985340&partnerID=8YFLogxK

M3 - Article

C2 - 10646703

AN - SCOPUS:0033985340

VL - 7

SP - 42

EP - 52

JO - Menopause

JF - Menopause

SN - 1072-3714

IS - 1

ER -